Literature DB >> 16939503

Oxygen supplementation increases glucose tolerance during euglycaemic hyperinsulinaemic glucose clamp procedure in patients with severe COPD and chronic hypoxaemia.

P Jakobsson1, L Jorfeldt.   

Abstract

Investigations in chronic obstructive pulmonary disease (COPD) patients have shown impaired glucose tolerance in hypoxic COPD patients, compared with COPD patients with normal arterial blood gases. In healthy subjects, hypoxaemia or stay at altitude, have been shown to alter glucose metabolism. At altitude the effect seems to be dependent on duration of stay. A short stay is associated with insulin resistance, a longer stay gives rise to increased glucose uptake. The euglycaemic hyperinsulinaemic glucose clamp technique is a method to study glucose tolerance and enables determinations of glucose clearance in peripheral tissues. We investigated six COPD patients [forced expiratory volume in 1 s 0.7 +/- 0.2 l (mean +/- SD)] with chronic hypoxaemia (PaO(2) 7.9 +/- 0.6 kPa at rest, breathing air), with and without oxygen supplementation, using the glucose clamp technique. Net peripheral glucose uptake was 5.5 +/- 1.2 and 7.1 +/- 1.6 mg (kg*min)(-1) (+29%) breathing air and supplemental oxygen, respectively (P = 0.03). The tissue sensitivity to insulin increased 32% (P = 0.03) with oxygen supplementation. The results indicate that normalization of oxygen saturation in COPD patients with chronic hypoxaemia may have an immediate effect on glucose tolerance and tissue sensitivity to insulin in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939503     DOI: 10.1111/j.1475-097X.2006.00686.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  14 in total

1.  Hyperoxia blunts counterregulation during hypoglycaemia in humans: possible role for the carotid bodies?

Authors:  Erica A Wehrwein; Rita Basu; Ananda Basu; Timothy B Curry; Robert A Rizza; Michael J Joyner
Journal:  J Physiol       Date:  2010-10-04       Impact factor: 5.182

2.  Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease.

Authors:  Christina C Kao; Jean W-C Hsu; Venkata Bandi; Nicola A Hanania; Farrah Kheradmand; Farook Jahoor
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

Review 3.  Glucose, insulin, and the carotid body chemoreceptors in humans.

Authors:  Jacqueline K Limberg
Journal:  Physiol Genomics       Date:  2018-04-13       Impact factor: 3.107

Review 4.  SPARC: a key player in the pathologies associated with obesity and diabetes.

Authors:  Katarina Kos; John P H Wilding
Journal:  Nat Rev Endocrinol       Date:  2010-03-02       Impact factor: 43.330

5.  Changes in the levels of cytokines in both diabetic/non-diabetic type I children living in a moderate altitude area in Saudi Arabia.

Authors:  Gamal Allam; Adnan A Alsulaimani; Hamed Alghamdi; Hameed Alswat; Burhan M Edrees; Iftikhar Ahmad; Amre Nasr
Journal:  High Alt Med Biol       Date:  2014-08-28       Impact factor: 1.981

Review 6.  Hypoxia-inducible factors and diabetes.

Authors:  Jenny E Gunton
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

7.  Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation.

Authors:  Katherine Stamatakis; Mark H Sanders; Brian Caffo; Helaine E Resnick; Dan J Gottlieb; Reena Mehra; Naresh M Punjabi
Journal:  Sleep       Date:  2008-07       Impact factor: 5.849

8.  Is insulin the new intermittent hypoxia?

Authors:  Jacqueline K Limberg; Timothy B Curry; Nanduri R Prabhakar; Michael J Joyner
Journal:  Med Hypotheses       Date:  2014-03-18       Impact factor: 1.538

Review 9.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2012-10-27       Impact factor: 9.951

10.  Glucose tolerance and weight loss in obese women with obstructive sleep apnea.

Authors:  Luisa Gilardini; Carolina Lombardi; Gabriella Redaelli; Luciana Vallone; Andrea Faini; Paola Mattaliano; Gianfranco Parati; Cecilia Invitti
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.